NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

I think the questions remain about the initial selection criteria. I’ve always said here a confirmatory trial is most likely but I disagree it’d need a control group given the advance in scanning. Perhaps a SurvaxM control?

>>It's possible there are questions about the control used here, but I feel that the most dire consequence this should lead to, in my opinion, is requiring another confirmatory trial with an enrolled control group, not an external comparator.